Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Jeff Gates, Gates Capital Buy Near 5% of Headwaters

Jeff Gates, Gates Capital: Headwaters Inc (NYSE:HW) has recently been added to the equity portfolio of Gates Capital Management, a hedge fund managed by Jeffrey Gates. In a 13G filing with the Securities and Exchange Commission, Gates Capital Management reported ownership of almost 3.7 million shares of Headwaters Inc, the stake being equivalent to around 5% of the company. At the current price of Headwaters’ stock, Gates’ position in the company has a value worth almost $32 million.

Headwaters Inc (NYSE:HW)

Headwaters posted an income of $9.3 million, equivalent to $0.13 per diluted share for the third quarter of fiscal 2013, which shows a surge from the last year’s amount of $2.0 million. The company also managed to increase its revenues by 12% on the year, to $197 million. For the whole fiscal 2013, Headwaters forecasts its EBITDA to be situated between $110 million and $125 million, the company said in a statement.

We should also mention some other hedgies that are bullish on Headwaters, according to Insider Monkey’s database. Eric Edidin and Josh Lobel’s Archer Capital Management, which disclosed ownership of around 3.1 million shares, Jim Simons’ Renaissance Technologies, and First Eagle Investment Management are long, in addition to Jeff Gates and Gates Capital..

Recommended Reading:

Look What the Koch Brothers Are Buying Now

Should Investors Follow Carl Icahn Into This Auto Supplier?

The Only Warren Buffett Pick Signaling ‘Buy’

Disclosure: none

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!